Use of recombinant luteinizing hormone for controlled ovarian hyperstimulation in infertile patients

JBRA Assist Reprod. 2016 May 1;20(2):78-81. doi: 10.5935/1518-0557.20160018.

Abstract

Controlled ovarian stimulation has become an integral part of a high complexity infertility treatment. Treatment options with recombinant gonadotrophins add more to knowledge on folliculogenesis and ovarian steroidogenesis. Therefore, a literature search was conducted in the following data bases: Medline, Scielo and PubMed. The descriptors/ key words used were ovarian stimulation, in vitro fertilization, recombinant luteinizing hormone, supplementation LH. The aim of this study was to review the available literature and to assess the benefits of using recombinant luteinizing hormone associated with recombinant follicle stimulating hormone in different populations who have undergone assisted reproduction procedures.

Keywords: in vitro fertilization; ovarian stimulation; supplementation LH.

Publication types

  • Review

MeSH terms

  • Female
  • Fertilization in Vitro*
  • Humans
  • Infertility, Female / therapy*
  • Luteinizing Hormone / therapeutic use*
  • Ovarian Hyperstimulation Syndrome / drug therapy*
  • Recombinant Proteins / therapeutic use*

Substances

  • Recombinant Proteins
  • Luteinizing Hormone